Logotype for Embla Medical

Embla Medical (EMBLA) investor relations material

Embla Medical Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Embla Medical
Q3 2025 earnings summary21 Oct, 2025

Executive summary

  • Q3 2025 sales reached USD 237 million (ISK 237 million), with 7% organic and 11% reported growth, driven by double-digit gains in Prosthetics & Neuro Orthotics and strong EMEA/APAC momentum.

  • Net profit increased 17% year-over-year for both Q3 and the first nine months, supported by strong operating results.

  • Strategic initiatives included majority investments in Streifeneder ortho.production and Fior & Gentz neuroorthotics, and the launch of Odyssey iQ bionic foot.

  • Patient Care and Bracing & Supports segments saw modest or flat growth, with internal changes and market challenges impacting results.

  • Full-year guidance reiterated: 5%-6% organic growth and 20%-21% EBITDA margin.

Financial highlights

  • Q3 net sales: USD 237 million (11% reported, 7% organic growth); 9M 2025 net sales: USD 672 million (7% reported, 5% organic growth).

  • EBITDA margin was 22% for Q3, 21% for nine months, up from 19% year-over-year.

  • Gross profit margin held at 63% for Q3 and nine months, up from 62% in the prior year.

  • Net profit: USD 26 million in Q3 (up 17% YoY); USD 59 million in 9M 2025 (up 17% YoY).

  • Free cash flow: USD 38 million in Q3, USD 58 million in 9M 2025; CapEx at 3% of sales in Q3.

Outlook and guidance

  • Full-year 2025 guidance reiterated: 5%-6% organic growth and 20%-21% EBITDA margin.

  • Second half expected to outperform first half, with Q3 performance supporting higher end of guidance.

  • Patient Care business expected to return to market growth rates by 2026 after integration and rebranding.

  • CapEx expected at 3%-4% of sales; effective tax rate guided at 23%-24%.

  • US trade tariffs and FX volatility remain key uncertainties, with some tariff absorption assumed in guidance.

Streifeneder: How does it expand O&P market reach?
Patient Care: Detail internal change initiatives?
US tariffs: Current status and mitigation plans?
Patient Care: When will growth align with market?
Tariff impact: What are long-term mitigation plans?
Fior & Gentz US: When will revenue impact?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Embla Medical earnings date

Logotype for Embla Medical
Q4 20253 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Embla Medical earnings date

Logotype for Embla Medical
Q4 20253 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Embla Medical hf, formerly known as Össur hf, is an Iceland-based company that operates in the medical equipment and supplies sector. The company specializes in non-invasive prosthetics, medical braces, and support solutions. Its product portfolio includes components for both lower and upper limb prosthetics and various bracing systems designed to assist patients with conditions like osteoarthritis. In addition to product development, Embla Medical also manages a network of patient care clinics that provide personalized mobility solutions and support services. The company's operations extend globally, serving markets across the Americas, Europe, and Asia. Embla Medical is headquartered in Reykjavik, Iceland, and its shares are listed on the Nasdaq Copenhagen.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage